Mr. López-Belmonte Encina graduated in Economic and Business Sciences from Colegio Universitario de Estudios Financieros (CUNEF), Madrid, specialising in Financing, in 1998. He obtained a joint Executive MBA from Brown University and the Instituto de Empresa in Madrid in 2017. He is a shareholder of Norbel Inversiones, S.L., where he holds 33% of the share capital (this company is, in turn, ROVI’s controlling shareholder) and 1 st Deputy Chairman of ROVI’s Board of Directors. He began his professional career in the banking sector in 1998, working for Argentaria, S.A. in the United Kingdom as an analyst, and in the pharmaceutical sector with Medeva Pharma, also in the United Kingdom. He joined ROVI in 2000 and has been Chief Financial Officer since 2001. He has been Vice President of CEIM, a member of its Management Board and Chairman of its Health Commission. Likewise, he has been a member of the Social Council of the Universidad Autónoma de Madrid representing CEIM and a member of the Board of Trustees of Fundación Universidad Autónoma de Madrid, representing the Social Council of the Universidad Autónoma de Madrid. He was initially appointed to the Company’s Board of Directors on 27 July, 2007 when ROVI was first listed on the securities markets and was re-elected at the General Shareholders’ Meetings held on 2012, 2017 and 2021.